Pantoprazole Sodium Injection, Powder, Lyophilized, For Solution
NDC Package 70095-024-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Pantoprazole Sodium injection is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Sun Pharmaceutical Industries Limited, this product is identified by NDC 70095-024 and is authorized under FDA application ANDA204400.

Identification & Billing

NDC Package Code
70095-024-03
Package Description
25 CARTON in 1 PACKAGE / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL (70095-024-01)
Product Code
70095-024
11-Digit Billing Format
70095002403
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pantoprazole Sodium
Non-Proprietary Name
Pantoprazole Sodium
Substance Name
Pantoprazole Sodium
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
PANTOPRAZOLE SODIUM 40 mg/10mL
Pharmacologic Class
Usage Information
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA204400
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-03-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J2470
Source: PDAC
INJECTION, PANTOPRAZOLE SODIUM, 40 MG
HCPCS Dosage 40 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70095-024). Click a package code to view its specific billing and regulatory data.

70095-024-02
10 CARTON in 1 PACKAGE / 1 VIAL in 1 CARTON / 10 mL in 1 VIAL (70095-024-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70095-024-03 identifies a specific commercial package of 25 carton in 1 package / 1 vial in 1 carton / 10 ml in 1 vial (70095-024-01) of Pantoprazole Sodium, a human prescription drug labeled by Sun Pharmaceutical Industries Limited. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains pantoprazole sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries Limited on April 03, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Sun Pharmaceutical Industries Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70095002403. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70095-024-03
11-Digit CMS (5-4-2)
70095-0024-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.